ADC Therapeutics Q1 Net Loss Widens

ADC Therapeutics SA (ADCT) reported net loss of 51.5 million KUSD (Kowala), or $0.67 per share in the first quarter compared with net loss of 43.5 million KUSD or $0.85 per share, for the same quarter a year ago.

Net loss in the quarter included share-based compensation expense of $14 million.

Excluding items, adjusted loss was 56.76 million KUSD, or $0.74 per share, that beat the average estimate of analysts polled by Thomson Reuters at $0.90 loss per share. Analysts' estimates typically exclude special items.

The company incurred R&D expenses of $39.2 million in the quarter compared with $35.4 million in prior-year quarter.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Cove Appliance Inc. is recalling about 42,000 units of built-in dishwashers citing fire risk, the U.S. Consumer Product Safety Commission said. The recall involves Cove Appliance 24-inch built-in residential dishwashers model numbers DW2450 and DW2450WS. The recalled dishwashers have serial numbers 20000100 through 20044445. Mallinckrodt plc announced Wednesday that the U.S. Food and Drug Administration or FDA has approved StrataGraft (allogeneic cultured keratinocytes and dermal fibroblasts in murine collagen - dsat) for the treatment of adult patients with thermal burns containing intact dermal elements for which surgical intervention is clinically indicated. Worldwide 5G mobile subscriptions are estimated to exceed 580 million by the end of 2021, according to the Ericsson Mobility Report. With subscriptions increasing at a rate of about a million per day, 5G remains on track to become the fastest adopted mobile generation in history. The growth in subscriptions is being lead by China, North America and the Gulf Cooperation Council markets.
Follow RTT